Cardiovascular Effects of Berberine: A Review of the Literature

Even though plants containing the alkaloid berberine have been used in Ayurvedic and Chinese medicine for over 2500 years, berberine’s potential cardiovascular and metabolic effects have been studied only in the recent past. The objective of this review is to summarize the effects and possible mechanisms of action of berberine when applied to various aspects of the cardiovascular system. Evidence is presented from experimental studies, clinical trials, and meta-analyses accessed via PubMed. Further research is needed, particularly clinical trials, but a growing body of evidence suggests an important role for berberine in the treatment of dyslipidemia, type 2 diabetes, and metabolic syndrome.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.14200/JRM.2017.6.0100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming berberine into its intestine-absorbable form by the gut microbiota

  2015cited by this paper
• Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice

  2015cited by this paper
• Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters

  2015cited by this paper
• Study progress of berberine for treating cardiovascular disease

  2015cited by this paper
• Current knowledge and pharmacological profile of berberine: An update.

  2015cited by this paper
• Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption.

  2014cited by this paper
• Barberry Treatment Reduces Serum Anti‐Heat Shock Protein 27 and 60 Antibody Titres and High‐sensitivity C‐reactive Protein in Patients with Metabolic Syndrome: A Double‐blind, Randomized Placebo‐controlled Trial

  2014cited by this paper
• Recent Clinical Advances with Berberine

  2010cited by this paper
• Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.

  2010cited by this paper
• Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters.

  2010cited by this paper
• Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.

  2010cited by this paper
• Cardiovascular and metabolic effects of Berberine.

  2010cited by this paper
• Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.

  2009cited by this paper
• Significant differences in alkaloid content of Coptis chinensis (Huanglian), from its related American species

  2009cited by this paper
• Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.

  2009cited by this paper
• Berberine improves glucose metabolism through induction of glycolysis.

  2008cited by this paper
• Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats.

  2008cited by this paper
• Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I

  2008cited by this paper
• [Effects of berberine on cell proliferation, peroxisome proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and protein expression in 3T3-L1 pre-adipocytes].

  2008cited by this paper
• Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.

  2008cited by this paper
• Berberine Activates GLUT 1-Mediated Glucose Uptake in 3 T 3L 1 Adipocytes

  2007cited by this paper
• [Effect of berberine on left ventricular remodeling in renovascular hypertensive rats].

  2007cited by this paper
• Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes

  2007cited by this paper
• Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States

  2006cited by this paper
• AMP-Activated Protein Kinase Is Involved in Endothelial NO Synthase Activation in Response to Shear Stress

  2006cited by this paper
• Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway.

  2006cited by this paper
• AMP-Activated Protein Kinase Signaling Stimulates VEGF Expression and Angiogenesis in Skeletal Muscle

  2005cited by this paper
• Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases.

  2005cited by this paper
• Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

  2004cited by this paper
• AMP-activated Protein Kinase (AMPK) Signaling in Endothelial Cells Is Essential for Angiogenesis in Response to Hypoxic Stress*

  2003cited by this paper
• Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

  2003cited by this paper
• Endothelial dysfunction.

  2003cited by this paper
• Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats.

  2002cited by this paper
• Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.

  2002cited by this paper
• Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells.

  2002cited by this paper
• The involvement of P-glycoprotein in berberine absorption.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Study on the interactions of berberine displace other drug from their plasma proteins binding sites

  2002cited by this paper
• Vasorelaxant and antiproliferative effects of berberine.

  2000cited by this paper
• The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells.

  1999cited by this paper
• Hypercholesterolemia and endothelial dysfunction.

  1995cited by this paper
• Displacement of bilirubin from albumin by berberine.

  1993cited by this paper
• Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs.

  1992cited by this paper
• Interaction of berberine with human platelet alpha 2 adrenoceptors.

  1991cited by this paper
• Cardiovascular effects of berberine in patients with severe congestive heart failure

  1988cited by this paper
• Identification of Mrna Binding Proteins That Regulate the Stability of Ldl Receptor Mrna through Au-rich Elements

  year unknowncited by this paper

• A 30-Day Randomized Crossover Human Study on the Safety and Tolerability of a New Micellar Berberine Formulation with Improved Bioavailability

  2025cites this paper
• Effects of berberine administration on insulin resistance, lipid profile and general health - Narrative Review

  2025influential citation
• Potential Health Effects of the Natural Alkaloid Berberine: A Narrative Review.

  2025cites this paper
• The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review

  2024cites this paper
• Controlling release and cytotoxicity with berberine-loaded KIT-6

  2024cites this paper
• Pharmaceutical Analysis of Berberine: An Update

  2024cites this paper
• Optimal synthesis conditions for NBF-modified 8,13-dihydroberberine derivatives

  2024cites this paper
• Therapeutic Efficacy of Albendazole and Berberine Loaded on Bovine Serum Albumin Nanoparticles on Intestinal and Muscular Phases of Experimental Trichinellosis.

  2023cites this paper
• Bioactive molecules from terrestrial and seafood resources in hypertension treatment: focus on molecular mechanisms and targeted therapies

  2023cites this paper
• Berberine as a Potential Agent for the Treatment of Colorectal Cancer

  2022cites this paper
• BERBERINE: A POTENT ADJUVANT IN PSORIASIS NANOTECHNOLOGY

  2022cites this paper
• Synthetic berberine derivatives as potential new drugs

  2022cites this paper
• Berberine in Non-Alcoholic Fatty Liver Disease—A Review

  2022influential citation
• Countering cardiovascular diseases with nutraceuticals

  2021cites this paper
• Nutraceuticals for diabetes and glucose balance

  2021cites this paper
• Natural Dyes from Three Invasive Plant Species in The United States

  2021cites this paper
• BERBERINE AND ITS PHARMACOLOGY POTENTIAL: A REVIEW

  2020cites this paper
• Solubility and Stability Advantages of a New Cocrystal of Berberine Chloride with Fumaric Acid.

  2020cites this paper
• Plants Used as Antihypertensive

  2020cites this paper
• Berberine for the treatment of hypertension: A systematic review.

  2020cites this paper
• Solubility and Stability Advantages of a New Cocrystal of Berberine Chloride with Fumaric Acid

  2020cites this paper
• Berberis microphylla: A Species with Phenotypic Plasticity in Different Climatic Conditions

  2018cites this paper